The Publication & Databases on
Biotechnology in the Asia Pacific
 
Current Issue

Vol.13 No.6
 Current Issue
 Special Issues
 Sample Issues
 Complimentary Copy
 E-Alert
 Editorial Board
 Article Contributions
 Editorial Calendar

Sponsored Links
Computational Systems Bioinformatics — Methods And Biomedical Applications
by Xiaobo Zhou & Stephen T C Wong (Harvard Medical School and Brigham & Women's Hospital, USA)

Biological Networks
Essential Resources for Human Survival
edited by François Képés (CNRS & University of Evry, France)

Current Topics In Human Genetics
Studies in Complex Diseases
edited by Hong-Wen Deng, Hui Shen (University of Missouri-Kansas City, USA), Yong-Jun Liu (University of Missouri-Kansas City, USA) & Hai Hu (Windber Research Institute, USA)

Advertisement
JavaScript Scroller - Sample #4 (Multiple Scrollers)
Advertisement

 

Feature Articles

Situation of Chinese Medicine in China
Chinese Medicine is a cultural achievement. The tradition has an unusually long history and a strong philosophical basis. The traditional practice has served the people of China for thousands of years, not only within mainland China, but also in Chinese communities outside China. With increasing disillusionment about the effectiveness of modern Western medicine, which commands a reductionist approach based on a single target concept, alternative medicine based on past experience has enjoyed a corresponding increase in positive attention. This apparently unusual development happened because Western medicine - in spite of its successes - has yet to solve all the difficult problems in clinical practice.

World's First Tetravalent Dengue Vaccine in Clinical Trial
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced in April this year the start of clinical studies of its investigational tetravalent dengue vaccine in Singapore and Vietnam. Sanofi pasteur is expanding its global dengue vaccine clinical study program in Asia where trials are already ongoing in Thailand and the Philippines. In Singapore, Sanofi Pasteur is collaborating with the Communicable Disease Centre to conduct a clinical study in 4 hospitals.

The aim is to collect useful information about the first tetravalent dengue vaccine candidate to reach the clinical phase and evaluate the incidence of disease among trial participants. Sanjeed finds out more from Dr Melanie Saville, Associate Vice President and Head, Clinical Dengue Programme in Sanofi Pasteur and Dr Ng Lee Ching, Head of Environmental Health Institute, National Environment Agency.
 

Contents page (Vol.13. No.6) >>more
Feature
•  Situation of Chinese Medicine in China
•  World's First Tetravalent Dengue Vaccine in Clinical Trial

Commentary and Analysis
•  Facing ITC Investigation? What Chinese Biotechnology Companies Should Know About Patent Litigation in the United States International Trade Commission

Industry Watch
•  "Off-The-Shelf" Stem Cell Treatment for Heart Failure
•  Cytopia Cancer Program Reaches Important Milestone at Cancer Therapeutics CRC
•  Starpharma and Elanco Agree to Develop New Products
•  China Sky One Medical, Inc. Achieves Significant Breakthrough In Sudden Cardiac Death (SCD) Early Examination Kit
•  Roche Applied Science opens Application Support Center in Shanghai
•  Luminex Expands Globally and Opens Facility in People's Republic of China
•  Genesis Pharmaceuticals Launches three New TCM Products
•  China Sky One Medical, Inc. to Develop New Anti-Cancer Drug with Taiwan Golden Biotechnology Corp
•  Solvay Pharmaceuticals Announces Strategic Partnership with HUYA to Access New Drug Candidates From China
•  Sinovac Receives $US12.9 mn Purchase Order for HealiveŽ from China's Ministry of Public Health
•  GE Launches Lullaby Warmer for Newborn in India
•  SymBio Pharmaceuticals Limited and Eisai Co., Ltd. Conclude License Agreement for Bendamustine Hydrochloride (SyB L-0501) in Korea and Singapore
•  Aperio Expands Global Digital Pathology Presence with New Subsidiary in Asia
•  Valeant Pharmaceuticals Grants Schering-Plough Exclusive Option in Japan for Taribavirin in Exchange
•  Genome Institute of Singapore and Roche NimbleGen Develop Rapid Approach to Identify H1N1 Virus Mutations and Resistance to Drugs

Research and Findings
•  Key Protein Regulating Inflammation May Prove Important in Controlling Sepsis
•  Tomato Pills Fight Heart Disease
•  Malaysian Scientists Decipher Oil Palm Genome

People Watch
•  Simcere Pharmaceutical Group Appoints Dr. Peng Wang as Chief Scientific Officer
•  Circadian Technologies Limited's Professor Kari Alitalo, Wins Prestigious Biomedical Research Award
•  Top Scientists to Further Research at A*Star
•  French Republic honors A*STAR Immunology Chairman

Conference Calendar

Hotel Accommodation: Asian booking service Agoda.com provides instant, secure online reservations for Hotels in Asia at very attractive rates.

Copyright © 2009 KH Biotech Services Pte Ltd. All rights reserved.
KH Biotech Services Pte Ltd is a subsidiary of World Scientific Publishing Co.